References
- da Cunha LP, Silveira MN, Mendes MCS, et al. Sarcopenia as an independent prognostic factor in patients with metastatic colorectal cancer: A retrospective evaluation. Clin Nutr ESPEN. 2019;32:107-112.10.1016/j.clnesp.2019.04.00431221274
- Herrod PJJ, Boyd-Carson H, Doleman B, et al. Quick and simple; psoas density measurement is an independent predictor of anastomotic leak and other complications after colorectal resection. Tech Coloproctol. 2019;23:129-134.10.1007/s10151-019-1928-0644110230790102
- Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489-495.10.1016/S1470-2045(10)70218-721296615
- Ferlay J, Ervik M, Lam F. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer, 2018. http://gco.iarc.fr/today/data/factsheets/cancers/10_8_9-Colorectum-fact-sheet.pdf (May 2022)
- American Cancer Society. Cancer Facts & Figures 2022: Special Section – Cancer in Adolescents and Young Adults. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2022/2022-cancer-facts-and-figures.pdf (May 2022)
- Sabel MS, Lee J, Cai S, Englesbe MJ, Holcombe S, Wang S. Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol. 2011;18:3579-3585.10.1245/s10434-011-1976-921822551
- Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009;15:6973-6979.10.1158/1078-0432.CCR-09-152519887488
- Chargi N, Bril SI, Emmelot-Vonk MH, de Bree R. Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer. Eur Arch Otorhinolaryngol. 2019;276:1475-1486.10.1007/s00405-019-05361-4645898430830300
- Pahor M, Manini T, Cesari M. Sarcopenia: clinical evaluation, biological markers and other evaluation tools. J Nutr Health Aging. 2009;13:724-728.10.1007/s12603-009-0204-9431265719657557
- Hile E, Hoffman L, Postier R, Ding K, Yang J, LiA M. A pilot RCT of sarcopenia-focused prehabilitation in pancreas cancer. J Clin Oncol. 2017;35:10127.10.1200/JCO.2017.35.15_suppl.TPS10127
- Mizuuchi Y, Tanabe Y, Sada M, et al. Cross-sectional area of psoas muscle as a predictive marker of anastomotic failure in male rectal cancer patients: Japanese single institutional retrospective observational study. Annals of Coloproctology. 2022; Online ahead of print.10.3393/ac.2022.00122.0017965034435410111
- Cespedes Feliciano EM, Avrutin E, Caan BJ, Boroian A, Mourtzakis M. Screening for low muscularity in colorectal cancer patients: a valid, clinic-friendly approach that pre-dicts mortality. J Cachexia Sarcopenia Muscle. 2018;9:898-908.10.1002/jcsm.12317620458530066490
- Levolger S, van Vugt JL, de Bruin RW, IJzermans JN. Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies. Br J Surg. 2015;102:1448-1458.10.1002/bjs.989326375617
- Choi MH, Oh SN, Lee IK, Oh ST, Won DD. Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer. J Cachexia Sarcopenia Muscle. 2018;9:53-59.10.1002/jcsm.12234580361928849630
- Lee CS, Won DD, Oh SN, et al. Prognostic role of pre-sarcopenia and body composition with long-term outcomes in obstructive colorectal cancer: a retrospective cohort study. World J Surg Oncol. 2020;18:230.10.1186/s12957-020-02006-3745637932859211
- Vergara-Fernandez O, Trejo-Avila M, Salgado-Nesme N. Sarcopenia in patients with colorectal cancer: A comprehensive review. World J Clin Cases. 2020;8:1188-1202.10.12998/wjcc.v8.i7.1188717661532337193
- Richards SJG, Senadeera SC, Frizelle FA. Sarcopenia, as Assessed by Psoas Cross-Sectional Area, Is Predictive of Adverse Postoperative Outcomes in Patients Undergoing Colorectal Cancer Surgery. Dis Colon Rectum. 2020;63:807-815.10.1097/DCR.000000000000163332149784
- Ida S, Watanabe M, Yoshida N, et al. Sarcopenia is a Predictor of Postoperative Respiratory Complications in Patients with Esophageal Cancer. Ann Surg Oncol. 2015;22:4432-4437.10.1245/s10434-015-4559-325862583
- Joglekar S, Asghar A, Mott SL, et al. Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma. J Surg Oncol. 2015;111:771-775.10.1002/jso.23862440685025556324
- Peng PD, van Vledder MG, Tsai S, et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford). 2011;13:439-446.10.1111/j.1477-2574.2011.00301.x313370921689226
- Jones KI, Doleman B, Scott S, Lund JN, Williams JP. Simple psoas cross-sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications. Colorectal Dis. 2015;17:O20-26.10.1111/codi.1280525328119
- Trotter J, Johnston J, Ng A, Gatt M, MacFie J, McNaught C. Is sarcopenia a useful predictor of outcome in patients after emergency laparotomy? A study using the NELA database. Ann R Coll Surg Engl. 2018;100:377-381.10.1308/rcsann.2017.0230595658929484927
- Benedek Z, Todor-Boér S, Kocsis L, Bauer O, Suciu N, Coroș MF. Psoas Muscle Index Defined by Computer Tomography Predicts the Presence of Postoperative Complications in Colorectal Cancer Surgery. Medicina (Kaunas). 2021;57:472.10.3390/medicina57050472815133634064607
- Deng CY, Lin YC, Wu JS, et al. Progressive Sarcopenia in Patients with Colorectal Cancer Predicts Survival. AJR Am J Roentgenol. 2018;210:526-532.10.2214/AJR.17.1802029364725
- Ojima Y, Harano M, Sumitani D, Okajima M. Impact of Preoperative Skeletal Muscle Mass and Quality on the Survival of Elderly Patients After Curative Resection of Colorectal Cancer. J Anus Rectum Colon. 2019;3:143-151.10.23922/jarc.2018-034684529031768464
- Baracos VE. Psoas as a sentinel muscle for sarcopenia: A flawed premise. J Cachexia Sarcopenia Muscle. 2017;8:527-528.10.1002/jcsm.12221556663528675689
- Yoshikawa T, Miyamoto M, Aoyama T, et al. Psoas muscle index at the fifth lumbar vertebra as a predictor of survival in epithelial ovarian cancers. Mol Clin Oncol. 2021;15:177.10.3892/mco.2021.2339827838034276996
- Rutten IJG, Ubachs J, Kruitwagen RFPM, Beets-Tan RGH, Olde Damink SWM, Van Gorp T. Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer. J Cachexia Sarcopenia Muscle. 2017;8:630-638.10.1002/jcsm.12180556663228513088